… (PET/CT) to magnetic resonance imaging (MRI) in the treatment response assessment of …
studies to compare the detectability of treatment response of [ 18 F]FDG PET/CT and MRI in …

… PET may be a useful measure to predict treatment response at … treatment. In contrast to
Gd-volumes on MRI, changes in 18 F-FET PET may be a valuable parameter to assess treatment …

… To investigate the use of [ 18 F]FLT-PET for assessment of early treatment response in
patients with AML. [ 18 F]FLT uptake in bone marrow was significantly lower in patients with CR …

… (iv) Treatment response should be evaluated by clinical examination and HN ceCT or MRI.
F-FDG PET/CT may be used to evaluate the response to … F-FDG PET/CT may be useful in the …

… A total of 34 patients (72%) achieved a complete metabolic response and had a median
survival of 24 mo; in comparison, the median survival of patients with a positive 18F-FDG …

… treatment response using … PET/CT for treatment response evaluation, in patients with
metastatic colorectal cancer who were treated with regorafenib, a multikinase inhibitor. FDG PET/…

… Tumor response on PET/CT has also shown promise for assessing treatment response for …
Our data, therefore, suggest that treatment monitoring with FDG PET/CT could benefit patients …

… Comparison of results of posttreatment PET and CT for the 19 lesions listed in Table 2. Note
… of PET for measurement of treatment response as compared with CT Posttreatment PET …

… We determined whether evaluation of treatment response is feasible by measuring … )
PET–CT (Positron emission tomography–Computed tomography). We compared the response …

Purpose: This study compares the value of 3,4-dihydroxy-6-[ 18 F]-fluoro-l-phenylalanine (
18 F-FDOPA) positron emission tomography (PET) and MRI in assessing outcome during …